TIM-3 therapy for Alzheimer's disease is emerging as a groundbreaking approach in the quest for effective treatments for this debilitating condition.Focusing on the role of the immune system's checkpoint molecules, this innovative strategy reawakens the brain's immune cells, known as microglia, to target and clear amyloid plaques responsible for cognitive decline.